Oil prices have moved higher again, and that has pushed government bond yields up in markets like the US, Germany and the UK. Cash and traditional bonds may feel safer, yet their rising yields also raise the bar for returns. This is where the Financially Fit Penny Stocks screener can help: it filters for lower risk balance sheets. Ahead, discover three stocks that stand out today.

The three stocks covered below are only a small sample, and the full Financially Fit Penny Stocks screen surfaces 324 more companies that also combine smaller share prices with balance sheets that aim for lower risk profiles. To identify and analyze those additional opportunities in one place, head straight into the Financially Fit Penny Stocks screener.

Enovix (ENVX)

Enovix is a Fremont based battery company that designs and manufactures lithium ion cells for wearables, IoT devices, smartphones, computing, electric vehicles and other equipment makers across the US and abroad. The business currently reports essentially all of its revenue from batteries and battery systems, at about $34 million. Enovix has a market cap of roughly $1.0b, which puts it in the smaller end of the listed battery and electrification space.

Enovix provides exposure to high energy density batteries that are designed to power future smartphones, defense equipment and smart eyewear, with new products like the MX 1 platform and custom AR or VR cells expected to matter as early as 2025. The attraction is rapid forecast revenue growth and exposure to premium niche uses. The trade off is a company that is still loss making, carries funding and execution risk, and is working to scale manufacturing in Malaysia under a new COO. For readers assessing whether the potential growth justifies these risks, the key considerations are the details of its balance sheet, production ramp and analyst expectations.

Enovix sits at the intersection of high energy smartphone and defense batteries, with a still loss making profile that raises real questions about funding. Get the analyst forecasts for Enovix to see what expectations might be missing.

Build your own high growth battery shortlist

Enovix and the two other stocks in this list all surfaced from a single Simply Wall St screen, but the real opportunity is tailoring filters to what matters most to you. Use our flexible Screener to blend growth, balance sheet strength and risk checks, or start with any of our curated Investing Ideas.

Clover Health Investments (CLOV)

Clover Health Investments runs Medicare Advantage plans in the US and also sells its Clover Assistant software that helps doctors manage chronic conditions. The company generated about US$2.5b of revenue from its Insurance segment, all in the United States. Clover Health has a market cap of roughly US$2.5b.

Clover Health Investments sits at an interesting crossroads for readers looking at healthcare stocks. The stock combines a technology heavy care model, growing Medicare Advantage membership and a software platform that can generate recurring revenue beyond insurance. At the same time, it still faces real questions around regulation, competition and funding structure. Recent results show rising revenue, a swing into GAAP profit and guidance that points to higher full year revenue and net income. Yet the shares still trade at a strong discount to Simply Wall St’s fair value estimate and only a modest premium to sales. The real question is whether the balance of cleaner earnings, star ratings progress and insider selling justifies a place on your watchlist.

Clover Health Investments is starting to look like a rare mix of recovering profitability and still muted expectations. Tap into the 4 key rewards and 1 important warning sign to see what might be quietly driving that gap wider.

Hyliion Holdings (HYLN)

Hyliion Holdings focuses on the KARNO Power Module, a fuel flexible generator designed for distributed power using everything from natural gas and diesel to landfill gas, hydrogen and ammonia. The company currently reports about $6 million in revenue from Auto Parts & Accessories, all generated in the United States. Hyliion Holdings has a market cap of roughly $690 million.

Hyliion Holdings sits at the intersection of cleaner power and rising demand for reliable electricity in data centers, industry and defense. Recent multi megawatt contracts with the U.S. Navy and Office of Naval Research, plus successful tests of multiple KARNO modules running together, show how the technology is being prepared for real world use. At the same time, the company is still loss making, has less than a year of cash runway and relies on higher risk external funding. For investors, the key question is whether the potential for revenue growth in AI power and military projects justifies the funding and execution risks that remain.

Hyliion Holdings sits in a rare position where early contracts and real world tests are beginning to build a story that the market may not yet fully recognize. Get the 1 key reward and 3 important warning signs (2 are major!)

Seeking Alternatives Before Momentum Flies

Fresh stock ideas can move from quiet to flying quickly. Use these focused lists before the best entry points are caught by the crowd. Act now.

• Spot potential high quality mispricings early by scanning the 51 high quality undervalued stocks. Position yourself before sentiment shifts catch up.
• Ride expanding demand for advanced computing by reviewing the 56 AI infrastructure stocks. Do this while these names are still under the radar for now.
• Target steady income potential by checking the 9 dividend fortresses. Do not delay while yields and balance sheet strength still line up.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.